No results for ‘’
Zydus Wellness Ltd
₹510.25
(0.20%)
Wed, 17 Jun 2026, 08:44 am
Consumer Non-Durables
Food: Major Diversified
24.5KZydus Wellness EV/EBITDA Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 30.85 | 18.18 | 10.53 | 9.61 | 32.93 | 39.24 | 21.96 | 17.48 | 20.14 | 36.42 | 28.12 | 31.17 | 34.23 | 32.38 | 52.77 | 100.93 | 30.92 | 31.78 | 35.07 | 30.66 |
| Price to book ratio | 4.51 | 2.11 | 1.96 | 3.32 | 14.83 | 16.45 | 7.95 | 6.61 | 5.97 | 9.77 | 6.07 | 6.10 | 6.63 | 2.21 | 2.16 | 2.75 | 1.97 | 1.93 | 1.75 | 1.88 |
| Price to sales ratio | 2.66 | 1.02 | 0.85 | 1.17 | 5.57 | 6.96 | 4.50 | 4.38 | 4.83 | 9.43 | 7.32 | 7.35 | 9.11 | 6.50 | 4.23 | 6.42 | 4.75 | 4.37 | 4.02 | 3.93 |
| Price to cash flow ratio | 18.54 | 10.88 | 0 | 4.98 | 24.72 | 46.27 | 22.76 | 21.08 | 18.37 | 41.39 | 24.13 | 31.50 | 46.79 | 39.21 | 60.05 | 62.38 | 44.70 | 124.82 | 40.02 | 28.79 |
| Enterprise value | 65.92Cr | 29.81Cr | 47.62Cr | 178Cr | 1392Cr | 2210Cr | 1356Cr | 1509Cr | 1680Cr | 3635Cr | 2514Cr | 2962Cr | 4060Cr | 6836Cr | 8806Cr | 12281Cr | 9740Cr | 10051Cr | 9372Cr | 10715Cr |
| Enterprise value to EBITDA ratio | 13.41 | 6.89 | 7.50 | 4.62 | 20.90 | 26.21 | 17.80 | 15.77 | 18.93 | 40.42 | 26.95 | 22.25 | 34.25 | 38.58 | 27.28 | 35.65 | 28.18 | 29.78 | 30.42 | 28.18 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.46 | 0.44 | 0.12 | 0.08 | 0.06 | 0.06 | 0.03 |
| Return on equity % | 0 | 12.73 | 20.22 | 50.94 | 53.40 | 49.06 | 41.17 | 43.80 | 33.14 | 29.78 | 23.35 | 21.04 | 21.45 | 8.30 | 4.14 | 2.96 | 6.56 | 6.23 | 5.09 | 6.29 |
Zydus Wellness Ltd Enterprise Value to EBITDA Ratio
The Zydus Wellness Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Zydus Wellness Ltd's valuation, profitability, and overall financial performance. Tracking the Zydus Wellness Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Zydus Wellness Ltd (NSE: ZYDUSWELL, BSE: 531335) is currently trading at ₹510.25, with a market capitalization of ₹16662.08Cr. As a leading company in the Consumer non-durables sector and Food: major diversified industry, monitoring the Zydus Wellness Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Zydus Wellness Ltd Enterprise Value to EBITDA Ratio Current Value
The current Zydus Wellness Ltd Enterprise Value to EBITDA Ratio stands at 28.18.
The Zydus Wellness Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Zydus Wellness Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Zydus Wellness Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 28.18
- 2023: 30.42
- 2022: 29.78
- 2021: 28.18
- 2020: 35.65
The decline in Zydus Wellness Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Zydus Wellness Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Zydus Wellness Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Zydus Wellness Ltd.
Zydus Wellness Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Zydus Wellness Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Zydus Wellness Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Zydus Wellness Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.